Back to search
FDAFDA · Food and drugs·Recall number D-0321-2024

Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67

Published February 21, 2024 · Recall initiated: January 25, 2024

Summary

FDA records drug Class III recall D-0321-2024, published February 21, 2024 and initiated January 25, 2024. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Ongoing; Reported quantity: 12,916 cartons; Lot: Lot #: 100042978, Exp 7/31/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email if NORTREL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NORTREL
Manufacturer
Teva Pharmaceuticals USA, Inc
Distributor
nationwide
Lot
Lot #: 100042978, Exp 7/31/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67 recalled?

Yes. FDA published recall D-0321-2024 on February 21, 2024. Reported hazard: Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NORTREL.